A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome

Clinical trial NCT00796003 · COMPLETED

Trial details

NCT number: NCT00796003
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2008-07-01
Primary completion: 2010-10-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.